Melatonin Alleviates High-Fructose-Induced Renal Injury in Male Mice, Which Might Be Associated with the Regulation of Mitophagy and Fatty Acid Oxidation

Y. Ma, Dan Sun, Yixian Bai, Weiheng Liu, Xue Bai, Liu Hon, Tian Kong, P. Wang, Xi Liang, Zheng Zhang, Hui Liang, Huaqi ZhangNutrients 2025 · DOI

TL;DR

This study investigates how melatonin (MLT) can protect against kidney damage caused by high fructose intake in male mice. The findings suggest that MLT alleviates this injury by promoting the clearance of damaged mitochondria (mitophagy) and enhancing the breakdown of fatty acids for energy (fatty acid oxidation), likely through the activation of AMPK signaling.

What Problem Does This Paper Address?

High fructose consumption, particularly from processed foods and beverages, has become a global health concern, with mounting evidence linking it to various health issues, including renal injury. While the detrimental effects of excessive fructose on the kidneys are recognized, the precise mechanisms and effective preventive strategies are still being explored. This paper aims to address this gap by investigating the potential renoprotective effects of melatonin, a naturally occurring compound known for its antioxidant and anti-inflammatory properties, against high-fructose-induced renal injury and to elucidate its underlying molecular mechanisms.

Methods

The researchers employed a controlled experimental design using male C57BL/6J mice. These mice were divided into four groups: a control group (CON), a melatonin-only group (MLT), a fructose-only group (FRU), and a group receiving both fructose and melatonin (FRU + MLT). The experiment lasted for 10 weeks, during which the FRU and FRU + MLT groups received a 30% fructose solution, while the MLT group received 10 mg/kg/day of melatonin via intragastric administration.

A comprehensive suite of analyses was performed on the mice:

  • Biochemical Analysis: Serum levels of creatinine (Cre), urea nitrogen (BUN), uric acid (UA), and triglycerides (TG) were measured to assess kidney function and metabolic status.
  • Histopathology: Hematoxylin and Eosin (H&E) staining was used to examine kidney tissue morphology, identifying structural damage like tubular dilatation and cell detachment. Oil Red O (ORO) and BODIPY staining were employed to visualize and quantify lipid accumulation in the kidneys.
  • Oxidative Stress and Inflammation Markers: Assays for reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), malondialdehyde (MDA), and inflammatory cytokines (IL-1β, IL-6, TNF-α) were conducted to evaluate cellular damage and inflammatory responses.
  • Mitochondrial Function and Mitophagy: Transmission Electron Microscopy (TEM) was used to observe mitochondrial ultrastructure and identify mitophagosomes. ATP content and mitochondrial DNA (mtDNA) copy number were measured as indicators of mitochondrial health and energy production. Immunofluorescence staining for LC3 (a mitophagy marker) and TOM20 (a mitochondrial marker) was performed to assess mitophagy.
  • Protein Expression Analysis: Western blot analysis was used to quantify the expression levels of key proteins involved in mitophagy (AMPK, p-AMPK, PINK1, Parkin, LC3 II, Beclin1, p62), mitochondrial dynamics (FIS1, Drp1, Mfn1, Mfn2, OPA1), and fatty acid oxidation (PPARα, CPT1A).

Datasets

Not discussed in the paper. The study utilized animal models and performed various biochemical and histological analyses on tissue and serum samples collected from these models.

Key Insights and Ideas

  • Fructose is a kidney toxin: The study reinforces that a high-fructose diet significantly impairs kidney function and structure, leading to increased markers of injury and lipid accumulation.
  • Melatonin as a renoprotective agent: Melatonin demonstrated a clear ability to mitigate the negative effects of fructose on the kidneys, improving both biochemical markers and histological damage.
  • Mitophagy is a key player: The research strongly implicates impaired mitophagy (the cell's process for clearing out damaged mitochondria) as a critical mechanism in fructose-induced kidney injury. Melatonin's ability to boost mitophagy appears central to its protective effect.
  • Fatty acid oxidation is linked: Melatonin also seems to restore fatty acid oxidation (FAO) pathways in the kidney, which are disrupted by high fructose. This suggests that maintaining proper energy metabolism in kidney cells is crucial.
  • AMPK as a central regulator: The study highlights the role of AMPK (AMP-activated protein kinase) as a potential upstream regulator, linking melatonin's action to both mitophagy and FAO.

Key Results

  • Improved Kidney Function: Melatonin treatment significantly reduced elevated serum levels of creatinine, BUN, and UA in fructose-fed mice. It also lowered kidney injury molecule-1 (KIM-1) and renal triglyceride levels.
  • Reduced Lipid Accumulation: Histological analysis (H&E, ORO, BODIPY staining) confirmed that melatonin alleviated renal tubular dilatation, brush border loss, epithelial cell detachment, and significantly reduced lipid accumulation in the kidneys.
  • Enhanced Mitophagy: TEM revealed an increase in autophagic vacuoles around mitochondria in MLT-treated mice. Immunofluorescence showed increased colocalization of LC3 and TOM20, indicating enhanced mitophagy.
  • Restored Mitochondrial Health: Melatonin treatment led to increased ATP content and mtDNA copy number, suggesting improved mitochondrial function.
  • Upregulated Mitophagy Proteins: Western blot analysis showed that MLT significantly increased the expression of p-AMPK, PINK1, Parkin, LC3 II, and Beclin1, while decreasing p62, all key components of the mitophagy pathway.
  • Enhanced Fatty Acid Oxidation: Melatonin upregulated the expression of FAO-related proteins, PPARα and CPT1A, in the kidneys.

Limitations and Future Work

The authors acknowledge several limitations:

  • Sex-Specific Effects: The study was conducted solely on male mice, precluding any assessment of sex-dependent effects of fructose or melatonin. Future studies should include female mice to address this.
  • Positive Control: The absence of a positive control group (a known renoprotective drug) limits the ability to benchmark melatonin's efficacy against established therapies.
  • Fructose Concentration: The 30% fructose solution used is significantly higher than typical human consumption levels. While this ensures robust injury induction, translational studies using more physiologically relevant fructose concentrations are needed.
  • Mechanistic Specificity: While the study strongly suggests AMPK activation as a mediator, further research is needed to definitively establish a sequential causality from MLT to AMPK activation to downstream effects. Functional assays for mitophagic flux and FAO rates, along with studies using AMPK-knockout models or specific inhibitors, would strengthen these findings.
  • Molecular Marker Reliance: The evidence for mitophagy and FAO relies on a limited set of molecular markers assessed by Western blot. Future work should incorporate functional assays to confirm these mechanisms.

Despite these limitations, the study provides compelling evidence for melatonin's renoprotective potential and highlights mitophagy and fatty acid oxidation as key therapeutic targets. Future research should focus on translating these findings to human applications, optimizing dosage, and further dissecting the intricate molecular pathways involved.

Summary updated

Abstract

<b>Objective</b>: To explore the preventive effect and mechanism of melatonin on high-fructose-induced renal injury in mice. <b>Methods</b>: A total of forty male C57BL/6J mice aged six weeks were randomly assigned to four groups: control group (CON), melatonin group (MLT), fructose group (FRU), and fructose + melatonin group (FRU + MLT). The concentration of the fructose solution was 30%, and the dose of melatonin was 10 mg/kg/day by intragastric administration. The experiment lasts for 10 weeks. <b>Results</b>: Liquid intake and energy intake were comparable between the FRU and FRU + MLT, both of which were significantly higher than that in the CON and MLT. MLT inhibited fructose-induced increased levels in serum creatinine (Cre), serum urea nitrogen (BUN), serum uric acid (UA), serum triglyceride (TG), renal kidney injury molecule-1 (KIM-1), and renal TG. Hematoxylin and Eosin (H&E) staining and Oil Red O (ORO) staining showed that MLT alleviated renal tubular dilatation, loss of brush border, epithelial cell detachment and lipid accumulation. Transmission electron microscope (TEM) observations showed that MLT increased autophagic vacuoles among mitochondria. Western blot analysis showed that, compared with the FRU, the FRU + MLT had elevated expression of AMP-activated protein kinase (AMPK) phosphorylation, along with a significant increase in the expression of its downstream mitophagy-related proteins (including PINK1, Parkin, LC3 II, and Beclin1), whereas the expression of p62 was markedly decreased. Furthermore, the expression levels of FAO-related proteins (including PPARα and CPT1A) in the FRU + MLT were significantly upregulated. <b>Conclusions</b>: MLT alleviates renal injury caused by high-fructose exposure in male mice and its mechanism might be associated with the regulation of mitophagy and fatty acid oxidation.
BibTeX
@inproceedings{ma2025melatonin,
  author = {Y. Ma and Dan Sun and Yixian Bai and Weiheng Liu and Xue Bai and Liu Hon and Tian Kong and P. Wang and Xi Liang and Zheng Zhang and Hui Liang and Huaqi Zhang},
  title = {{Melatonin Alleviates High-Fructose-Induced Renal Injury in Male Mice, Which Might Be Associated with the Regulation of Mitophagy and Fatty Acid Oxidation}},
  booktitle = {Nutrients},
  year = {2025},
  doi = {10.3390/nu18010068},
}
Figure